The Ministry of Science and Technology of China Eleventh 5-year Plan – Technical Platform for Drug Development

Technical Platform for the Clinical Research in Drug Development – New Drug Development for Chronic Hepatitis-B

The Ministry of Science and Technology of China had setup the Technical Platform for the Clinical Research in Drug Development – New Drug Development for Chronic Hepatitis-B as one of the major projects of the China’s 11th Five-Year Plan. The open ceremony for the Technical Platform had been held in Shanghai on 11 July 2009. The attendants of the ceremony including Dr. Wang Longxing, Director of the Shanghai Food and Drug Administration; Ms. Chen Pei, Secretary of Shanghai Renji Hospital; Professor Huang Yiran, President of Shanghai Renji Hospital; Professor Zeng Minde, Project Chief Consultant, Shanghai Renji Hospital; and Professor Benny Chung-Ying Zee, Director of Centre for Clinical of the Chinese University of Hong Kong. Professor Zee was invited by the Technical Platform Committee to join the advisory board for the clinical research development of chronic hepatitis-B. Professor Zee will provide professional consultation on the clinical study design and promote international quality system in clinical research in mainland China.

國家科技部十一五‘ 重大新藥創制 ’科技重大專項課題

新藥臨床研究技術平台建設 — 抗慢性乙型病毒性肝炎新藥臨床評價研究平台

國家科技部十一五『重大新藥創制』，新藥臨床研究技術平台建設—抗慢性乙型病毒性肝炎新藥臨床評 價研究平台啟動會議在2009年7月11日於上海舉行。與會者包括上海市國家食品藥品監督管理局王龍興局長，仁濟醫院陳佩書記、黃翼然院長、曾民德教授﹝ 總顧問﹞，以及香港中文大學臨床試驗中心主管徐仲鍈教授等。徐教授被邀參與總課題學術顧問委員會，為中國新藥臨床研究技術平台的建設，特別是抗在慢性乙型 病毒性肝炎的新藥臨床研究上提供專業意見及推動臨床研究國際化規範的發展。